share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  05/01 15:42
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年4月30日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節,包括股票數量、交易價格和總價值。採取行動後,沒有提供Bourla持有的最新股票數量。該交易是公司高管定期披露財務信息的一部分,投資者密切關注這些披露,以深入了解高管信心和公司業績。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年4月30日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節,包括股票數量、交易價格和總價值。採取行動後,沒有提供Bourla持有的最新股票數量。該交易是公司高管定期披露財務信息的一部分,投資者密切關注這些披露,以深入了解高管信心和公司業績。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息